Schedule 13D ownership disclosure
KINNATE BIOPHARMA INC
Security class unavailable · CUSIP: 49705R105
Event date: 2023-11-13
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 20.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950142-23-002786
- Form type
- SC 13D
- Filer
- Foresite Capital Fund V, L.P.
- CIK
- CIK 1792204
- Filed
- Nov 14, 2023
- Reporting period
- Nov 13, 2023
- Description
- Schedule 13D beneficial ownership